Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
D-Glucose-6-phosphate is formed in cells when glucose is phosphorylated by hexokinase (or glucokinase) or by the conversion of glucose-1-phosphate by phosphoglucomutase, which is the first step of glycogen synthesis.1 It is stored as glycogen when blood glucose levels are high. Disruption of D-glucose-6-phosphate activity leads to glycogen storage disease type I or von Gierke’s disease, a group of inherited metabolic diseases characterized by severe hypoglycemia, growth retardation, and hepatomegaly, due to accumulation of glycogen and fat in the liver.2,3 D-Glucose-6-phosphate is also the starting molecule of both glycolysis and the pentose phosphate pathways.4 Because cancer cells adopt glycolysis as a major source of metabolic energy production, and the pentose phosphate pathway plays a role in helping glycolytic cancer cells to meet their anabolic demands, this compound can be used to study the progression of this process.5
WARNING This product is not for human or veterinary use.
1. Section 25.5 NAD+, FAD, and coenzyme A are formed from ATP. Biochemistry 5th edition, (2002).
2. Glucose-
3. Glucose-
4. The pentose phosphate pathway of glucose metabolism: Enzyme profiles and transient and steady-
5. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39(8), 347-354 (2014).